"In 2021 verkozen tot de top 10 best beoordeelde klinieken van Nederland door patiëntenfederatie Nederland! Boerhaave Medisch Centrum is de grootste en beste kliniek voor plastische chirurgie. We zijn 365 dagen per jaar van 07.00 tot 22.00 voor u geopend. U bent altijd welkom voor een gratis en vrijblijvend consult!"

During the past decade, Boerhaave Medisch Centrum conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Boerhaave Medisch Centrum" are "Chronic Cluster Headache" (1 trials), "Episodic Cluster Headache" (1 trials) and "Migraine" (1 trials). Many other conditions were trialed in "Boerhaave Medisch Centrum" in a lesser frequency.

Most popular intervention types in "Boerhaave Medisch Centrum" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Galcanezumab" (1 trials), "Lasmiditan" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Boerhaave Medisch Centrum" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Boerhaave Medisch Centrum". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Boerhaave Medisch Centrum, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Boerhaave Medisch Centrum, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".